Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in COVID-19

Clover Starts Phase III Trial of COVID Vaccine as a Booster to Other Vaccines
Junshi’s Novel SARS-CoV-2 Therapy Out-Performs Pfizer’s Paxlovid
CanSino One-Shot COVID Vaccine Accepted by WHO
Ascentage Oncology Drug Effective in Preclinical Tests for COVID Cytokine Storm
RVAC Completes B Round for mRNA Drugs, Bringing Total Raised to $140 Million
ChinaBio Event
Beijing and Digital
November 8-11, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022